These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9115467)

  • 21. Tourette syndrome. Neuropsychological tests for obsessive-compulsive disorder and attention deficit hyperactivity disorder.
    Como PG
    Neurol Clin; 1997 May; 15(2):255-65. PubMed ID: 9115459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of Executive Functioning in a Small Sample of Children With Tourette Syndrome.
    Schwam DM; King TZ; Greenberg D
    Appl Neuropsychol Child; 2015; 4(4):297-308. PubMed ID: 25495678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological correlates of obsessive characteristics in Tourette syndrome.
    Bornstein RA
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):157-62. PubMed ID: 1821229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neurobiological model for Tourette syndrome centered on the nucleus accumbens.
    Brito GN
    Med Hypotheses; 1997 Aug; 49(2):133-42. PubMed ID: 9278925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothesis III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome.
    Palumbo D; Maughan A; Kurlan R
    Arch Neurol; 1997 Apr; 54(4):475-83. PubMed ID: 9109750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrality of prefrontal and motor preparation cortices to Tourette Syndrome revealed by meta-analysis of task-based neuroimaging studies.
    Polyanska L; Critchley HD; Rae CL
    Neuroimage Clin; 2017; 16():257-267. PubMed ID: 28831377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tourette Syndrome: Update.
    Hallett M
    Brain Dev; 2015 Aug; 37(7):651-5. PubMed ID: 25604739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
    Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
    Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tourette syndrome.
    Abi-Jaoude E; Gorman DA
    CMAJ; 2013 Feb; 185(3):236. PubMed ID: 23091179
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurobiology of Tourette Syndrome].
    Ünal D; Akdemir D
    Turk Psikiyatri Derg; 2016; 27(4):275-285. PubMed ID: 28046197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive-compulsive disorder in Tourette syndrome.
    Hounie AG; do Rosario-Campos MC; Diniz JB; Shavitt RG; Ferrão YA; Lopes AC; Mercadante MT; Busatto GF; Miguel EC
    Adv Neurol; 2006; 99():22-38. PubMed ID: 16536350
    [No Abstract]   [Full Text] [Related]  

  • 32. The neuropsychiatry of Gilles de la Tourette syndrome: The état de l'art.
    Cavanna AE
    Rev Neurol (Paris); 2018 Nov; 174(9):621-627. PubMed ID: 30098800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromotor functioning in children with Tourette syndrome with and without attention deficit hyperactivity disorder.
    Schuerholz LJ; Cutting L; Mazzocco MM; Singer HS; Denckla MB
    J Child Neurol; 1997 Oct; 12(7):438-42. PubMed ID: 9373800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Schizophrenic psychosis in a patient with Gilles de la Tourette syndrome].
    Becker T; Laux G; Sofic E; Riederer P; Beckmann H
    Nervenarzt; 1988 Oct; 59(10):616-20. PubMed ID: 2907104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities.
    Singer HS; Minzer K
    Brain Dev; 2003 Dec; 25 Suppl 1():S70-84. PubMed ID: 14980376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroimaging techniques in the Gilles de la Tourette syndrome].
    Lampreave JL; Bittini A; Mateos F; Manzano S; Domínguez P
    Rev Neurol; 1996 Aug; 24(132):921-5. PubMed ID: 8755353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contingent negative variation in Gilles de la Tourette syndrome.
    Weate SJ; Newell SA; Bogner JE; Andrews JM; Drake ME
    Clin Electroencephalogr; 1993 Oct; 24(4):188-91. PubMed ID: 8261641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome.
    Orth M; Rothwell JC
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):29-34. PubMed ID: 18931001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
    Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
    Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
    Kern JK; Geier DA; King PG; Sykes LK; Mehta JA; Geier MR
    Brain Connect; 2015 Aug; 5(6):321-35. PubMed ID: 25602622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.